Kings Path Partners LLC Ligand Pharmaceuticals Inc Transaction History
Kings Path Partners LLC
- $212 Billion
- Q2 2024
A detailed history of Kings Path Partners LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kings Path Partners LLC holds 6,880 shares of LGND stock, worth $713,318. This represents 0.27% of its overall portfolio holdings.
Number of Shares
6,880Holding current value
$713,318% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
247Shares Held
17.5MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$298 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$200 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$105 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$100 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX709KShares$73.5 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.75B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...